AngioDynamics (NASDAQ:ANGO) Issues Earnings Results, Beats Estimates By $0.03 EPS

AngioDynamics (NASDAQ:ANGO) released its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.03, MarketWatch Earnings reports. AngioDynamics had a positive return on equity of 0.18% and a negative net margin of 62.90%. The firm had revenue of $72.80 million for the quarter, compared to analysts’ expectations of $67.33 million. During the same period in the prior year, the firm earned $0.06 EPS. The company’s revenue was up 4.0% compared to the same quarter last year.

ANGO traded down $0.12 during midday trading on Friday, reaching $18.45. The company had a trading volume of 12,748 shares, compared to its average volume of 240,508. The business has a 50-day moving average of $14.29 and a two-hundred day moving average of $11.16. The company has a quick ratio of 2.25, a current ratio of 3.57 and a debt-to-equity ratio of 0.09. AngioDynamics has a 1 year low of $7.48 and a 1 year high of $19.52. The company has a market cap of $700.18 million, a P/E ratio of -4.18 and a beta of 0.89.

A number of research firms recently commented on ANGO. Raymond James upped their price objective on AngioDynamics from $18.00 to $24.00 and gave the company a “strong-buy” rating in a research report on Friday. Canaccord Genuity upped their price target on shares of AngioDynamics from $14.00 to $18.00 and gave the company a “hold” rating in a research report on Friday. BidaskClub raised shares of AngioDynamics from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Zacks Investment Research cut shares of AngioDynamics from a “buy” rating to a “hold” rating and set a $15.00 target price for the company. in a report on Tuesday, December 1st. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. AngioDynamics presently has an average rating of “Buy” and a consensus price target of $19.00.

About AngioDynamics

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.

Read More: What is the definition of market timing?

Earnings History for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit